HeyJaredValue & Momentum Portfolio
I'm Denis D., a private investor and former Lazard and Rothschild M&A banker. I do the deep fundamental work most won't on under-covered names, and run proprietary quantitative screens with clear verdicts and conviction level.
- Indexed issues, last 90 days
- 15
- Latest publication
- Sep 29, 2026
- Audience
- Checking…
- Earliest in this view
- Sep 9, 2026
Latest issues
Buy Alert: A Legacy Tech Name Is Quietly Becoming a High-Growth Software Story (opens the original)
Read excerpt
A legacy technology name is quietly turning into something very different. Its fastest-growing software business just posted roughly 27% year-over-year growth, management raised guidance again, and a new commercial platform win added more than $100 million to an already substantial royalty backlog. The most interesting part is not just higher unit volumes, but the potential for materially more software content per end product.If that shift proves repeatable, I think the market may still be under
Buy Alert: A biotech witch an asymmetric payoff (opens the original)
Read excerpt
A small drug company just launched a new treatment for thyroid eye disease, a condition that makes the eyes bulge and can threaten vision. The only big drug on the market today works well but requires many long hospital infusions. This new version works about as well, with fewer and shorter visits.The same company is also building a second version that patients can inject themselves at home, less often than the home version the current market leader is developing.The stock looks cheap because in
Buy Alert: A Cash-Rich Commodity Producer Entering Its Next Growth Phase (opens the original)
Read excerpt
This is a profitable European commodity producer entering a potentially important growth phase with a strong balance sheet and substantial net cash. Its existing operation already generates meaningful cash flow, while a pipeline of brownfield projects could materially expand production without relying on a highly leveraged funding model. The shares have already rerated, so the opportunity now depends less on simple multiple expansion and more on successful permitting, cost discipline and executi
Sprout Social (SPT): Stock Target Price Forecast & Full Valuation Analysis (Sept. 2026) (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="432" src="https://substackcdn.com/image/fetch/$s_!As0H!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F1ecc00b3-6b36-4dfa-b086-d585192e0034_768x432.webp"
Buy Alert: High FCF Yield, Expanding Margins, Mispriced Duration (opens the original)
Read excerpt
This is a mature, highly cash-generative business whose growth has slowed, but whose margins, free cash flow and per-share economics continue to improve.The market has aggressively compressed the valuation, creating a setup where I estimate a ~20% probability-weighted IRR over 3 years, with meaningful upside if cash-flow durability holds and the multiple simply normalizes.In this short article , I break down the growth slowdown, margin expansion, AI risk, valuation gap, takeover optionality, tec
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.